GÜVENÇ DOĞAN, Arzu Akdağlı EKİCİ, Elif AŞICI, SELÇUK KAYIR

Mortal Seyreden Tetanoz Vakası: Olgu Sunumu

Tetanoz nadir görülen, akut gelişen ve ileri yaşlarda ölümcül seyredebilen Clostridium tetani kaynaklı nörotoksinlerle oluşan, dirençli tonik spazmlarla karakterize bir hastalıktır. Solunum kasları tutulumu sonucu gelişen solunum sıkıntısı en ciddi bulgudur. Hastalarda görülen solunum yetersizliği ve hava yolu tıkanıklığı sıklıkla ventilatör desteği gerektirmektedir. Olgumuz 68 yaşında, uygun immünizasyonu olmayan, jeneralize tip tetanoz tanısı alıp sonrasında solunum yetmezliği gelişen bir olguydu. Entübe edilerek yoğun bakım ünitesine alındı. Sedasyon sağlanarak 11 gün mekanik ventilatör desteği aldı. Gelişen otonomik disfonksiyonları tedaviye rağmen düzeltilemedi. Hasta 11. günde ex oldu.

Tetanus Case with Mortal: A Case Report

Tetanus is a rare disease characterized by resistant tonic spasms that develop with acute and neurotoxins originating from Clostridium tetani, which are fatal to older ages. Respiratory distress resulting from respiratory muscle involvement is the most serious finding. Respiratory failure and airway obstruction in patients often require ventilator support. Our case was a 68-year-old woman with generalized type of tetanus without proper immunization and subsequent respiratory failure. He was enrolled and taken to intensive care unit. Sedation was provided and mechanical ventilator support was obtained for 11 days. The developing autonomic dysfunctions could not be corrected despite treatment. The patient died on the 11th day.

PDF

___

1. Center for Disease Control and Prevention. Epidemiology and Prevention of Vaccine Preventable Disease. Atkinson W, HamborskyJ, Mclntyre L, Wolfe S,(eds) 9th ed. Washington DC: Public Healty Foundation, 2006.
2. Bleck TP. Clostridium tetani(tetanus). In: Mandell GL, Bennet JE, Dolin R, editors. Mandell, Douglas, and Bennett's Principle and Practice of Infectious Disease. 6th ed.Philadelpdia: Elsevier, Churchill Livingstone; 2005.p. 2817-22.
3. Dire DJ. Tetanus, in eMedicine(ed):emedicineInstant Access to the Minds of Medicine, 2005.Available at.
4. Rhee P, Nunley MK, Demetrides D, Velmahos G, Doucet JJ. Tetanus and trauma: a review and recommendations. J Trauma 2005;58(5):1082-8.
5. Blake PA Feldman RA, Buchanan TM, et al: Serologic threrapy of tetanus in theUnited States, 1965-1971.JAMA 235(1):42-44,1976.
6. Attygalle D, Rodrigo N. Magnesium sulphate for control of spasms in severe tetanus. Can we avoid sedation and artifical ventilation? Anaesthesia 1997;52(10):956-62.
7. Calalcante NJ, Santaville MI, Mederios EA: Incidance of and risk factor for nosocomial pneumonia in patients with tetanus. Clin Infect Dis 33(11):1842-1846, 2001.
8. Kanarek DJ, Kaufman B, Zwi S: Severe sympathetic hyperactivity associated with tetanus. Arch Intern Med 132(4).602 -604,1973.
9. Mitra RC, Gupta RD, Sack RB: Electrocardiographic changes in tetanus: a serial study. J Indian Med Assoc 89(6):164-167,1991.
10. Bleck TP: Clostridium tetani, in Mandell B, Dolin (ed):Principles and practice of Infectious Diseases. Philadelphia, Elsevier-Churchill Livingstone, 2005, pp 2817-2822.
11. Nolla-Salas M, Garces-Brusesj: Severity of tetanus in patient older than 80 years: comparative study with younger patients. Clin Infect DİS 16(4):591-592, 1993.